Motif Bio Share Discussion Threads

[zen12] 28/1/2020 15:38

You're right, higher chance of sale happening now as they have got rid of CEO and appointed EOfficers. Read back to Nov RNS they had to appoint these guys to do the sale!John Palmer of Tamarack Associates is being appointed as sole Executive Officer of Motif Inc. and Bernadette Barron of Barron Business Consultants is being appointed as the sole, independent non-executive officer of Motif Inc. Concurrent with these appointments, Graham Lumsden, Jonathan Gold, and David Huang have resigned as officers of Motif Inc. and Graham Lumsden has resigned as director of Motif Inc.

[profit7] 28/1/2020 12:22

What if a buyer is found or another Bio seeking to list on the markets

Food for thought

[dice1950] 28/1/2020 08:54

MTFB Motif Bio a step closer to cash shell status after agreement with its main lender

[squintyflinty1] 28/1/2020 08:51

The end is here I'm afraid.The B.O.D are shameful.They have run this company into the ground and have been paid handsomely for it.I hope they don't get another job for as long as they live.

[tomboyb] 28/1/2020 08:42

End of this company -

52 week year high 44p to 0.14p -

Casino -

[zen12] 28/1/2020 08:38

That was always the case fella...this was last Nov news!

[enewman36] 28/1/2020 07:48

Such a shame, I was heavily invested here but 6 months to live now before being delisted (unless a buyer found), even less if no cash found under the sofa.

[smcl] 22/1/2020 18:22

Agreed. It’s up to the individual to invest or not.

It’s a gamble but maybe not the worst.

That’s my opinion but make up your own mind

[small crow] 22/1/2020 17:47

It's simple really - there are just lots of unknowns. So it's a gamble that some people will take and some won't. No-one knows the "truth" here because it's all in the future and the future is incredibly unpredictable.

[zen12] 22/1/2020 17:36

Also I terms of how much it's going to cost...this is no rocket science as the company RNS confirmed this back in Nov 19! 'This is in light of the Directors belief that, following the guidance received during the FDA meeting on 19 September 2019, it would take several years and tens of millions of Dollars to enrol and complete a HABP/VABP Phase III trial for which the Directors further believe that a partner or other entity with a lower cost of capital would be better positioned to support.'

[zen12] 22/1/2020 17:33

History is also abound by missed opportunities. So, let's leave it at that shall we..

[vulgaris] 22/1/2020 16:52

The fact that folks have poured millions into something does not prove that it is valuable. History abound with examples where folks have done so and got nothing back, from 1720 to the dotcom boom at the turn of the century.

Another trial will take tens of millions and, at best, will deliver a 'to be used with caution' type of license. Which is hopeless in a genericised market.

[zen12] 22/1/2020 16:37

How can it be poor drug lol company and predecessors have spend millions but you know better lolFDA did NOT reject this drug, so it has merits. They want another trial and they have worked with company to specify exact design of this trial. So again I see you know better that FDA and these pharma companies and investors who have spent many million $ in getting this drug this far!

[vulgaris] 22/1/2020 16:28

Iclaprim is as dead as a Norwegian Blue.

There are several now-generic products consistently active vs. MRSA - iclaprim's main target bug. What's more iclaprim has failed to satisfy the FDA in two rounds of clinical trials, first with Arpida and now with Motif.

No company in its right mind would pick this drug up. Even antibiotic companies with decent licensed products (Achaogen, Melinta and Tetraphase) have hit serous problems.... this is a poor drug in a medical field with severe problems.

[small crow] 22/1/2020 15:51

Except no-one has claimed that...

[small crow] 22/1/2020 15:33

Cheapest ever buy of a single share? Guiness Book of Records??

[philoosh] 22/1/2020 15:30

But surely interested parties will just buy the drug, not the company ? The shares in Motif would still be worthless?

[zen12] 22/1/2020 15:30

1 code now make it what you want

[zen12] 22/1/2020 15:18

Blow out coming..

[zen12] 22/1/2020 14:55

Remember it's a $3Bn market so it's no brainer that there will be interested parties. In terms of funding thought the same..but someone rightly pointed out that they have around 1m at end of Nov. With no further expenses on the drug and resignation of around 4xdirectors there should be enough to last around 6months. So my guess is some news on sale..time will tell.z

[iamgreat1] 22/1/2020 14:37

New placing soon

[philoosh] 22/1/2020 14:27

0.42 is no where near where I bought in for.

[zen12] 22/1/2020 13:28

Should be at least 0.42, this is the price of the warrants that Hercules hold even before any news..